Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Discover wealth building funds that offer high ROI to enhance your financial strategy. Learn how to grow your wealth effectively.
25,196 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Oil breaks through $119 as geopolitical risk spikes. This article explains why this nuclear energy stock may stand ou...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
March brought a mix of regulatory headlines and upbeat AI-related gains. This article breaks down what happened in th...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
Binance unveils a regional communications push, introduces new perpetual contracts, and plans to drop select trading ...
A new study shows Gen Z treats streaming like short-term rentals, churning between services and titles, challenging t...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...
Pfizer's stock has lagged since 2021, but the story isn’t over. This guide breaks down why pfizer stock: still priced...
Qualcomm and Micron lead another leg higher in the AI semiconductor rally, as data center demand and memory tightness...
TSMC delivered a stronger-than-expected Q1 2026, lifting full-year targets as AI demand powers the cycle, fueling the...